Alimera Sciences - Stock Price History | ALIM

Historical daily share price chart and data for Alimera Sciences since 2020 adjusted for splits. The latest closing stock price for Alimera Sciences as of September 18, 2020 is 5.70.
  • The all-time high Alimera Sciences stock closing price was 182.76 on November 24, 2010.
  • The Alimera Sciences 52-week high stock price is 10.34, which is 81.4% above the current share price.
  • The Alimera Sciences 52-week low stock price is 0.00, which is 100% below the current share price.
  • The average Alimera Sciences stock price for the last 52 weeks is 5.86.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Alimera Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 11.0201 12.7436 17.8411 3.2984 7.5800 -29.59%
2018 15.3653 19.7901 20.3748 10.7661 10.7661 -46.01%
2017 20.3933 16.7916 25.3253 16.7916 19.9400 23.15%
2016 24.6991 37.0315 39.7301 15.8921 16.1919 -55.37%
2015 61.5799 87.1064 87.8561 30.2849 36.2819 -56.32%
2014 87.9682 69.1154 118.2909 65.9670 83.0585 17.87%
2013 49.6127 24.4378 80.9595 24.4378 70.4648 199.36%
2012 37.6850 19.7901 65.5172 18.6057 23.5382 25.60%
2011 107.7149 160.7196 161.4693 17.5412 18.7406 -87.96%
2010 141.4225 164.9175 182.7586 99.2504 155.6222 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.029B $0.054B
Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes these diseases are not well treated with current therapies and represent a significant market opportunity. Its product candidate Iluvien(R) is an intravitreal insert containing fluocinolone acetonide, a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. Iluvien is in development for the treatment of diabetic macular edema (DME). DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.088B 15.76
Bristol Myers Squibb (BMY) United States $134.110B 10.33
CSL (CSLLY) Australia $93.977B 0.00
Gilead Sciences (GILD) United States $81.555B 11.74
Vertex Pharmaceuticals (VRTX) United States $69.125B 38.57
Regeneron Pharmaceuticals (REGN) United States $59.073B 22.59
Biogen (BIIB) United States $43.454B 7.44
Illumina (ILMN) United States $43.143B 50.17
Seattle Genetics (SGEN) United States $31.483B 0.00
Moderna (MRNA) United States $27.570B 0.00
Genmab (GMAB) Denmark $25.300B 15.98
Alexion Pharmaceuticals (ALXN) United States $24.924B 10.39
BeiGene (BGNE) Cayman Islands $24.766B 0.00
Genmab (GNMSF) Denmark $23.997B 5.53
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.148B 0.00
Immunomedics (IMMU) United States $19.770B 0.00
Incyte (INCY) United States $18.981B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.502B 38.61
Alnylam Pharmaceuticals (ALNY) United States $15.338B 0.00
BioNTech SE (BNTX) Germany $15.160B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.059B 68.11
BioMarin Pharmaceutical (BMRN) United States $14.396B 104.45
ARGENX SE-ADR (ARGX) Netherlands $11.740B 0.00
Exact Sciences (EXAS) United States $11.633B 0.00
QIAGEN (QGEN) Netherlands $11.522B 29.24
Sarepta Therapeutics (SRPT) United States $11.346B 0.00
Guardant Health (GH) United States $10.191B 0.00
Bio-Techne Corp (TECH) United States $9.404B 64.52
Galapagos (GLPG) Belgium $9.087B 32.92
Exelixis (EXEL) United States $8.281B 30.11
SWEDISH ORP BIO (BIOVF) Sweden $7.799B 19.40
Ascendis Pharma (ASND) Denmark $7.768B 0.00
Repligen (RGEN) United States $7.665B 121.66
MyoKardia (MYOK) United States $7.238B 0.00
Mirati Therapeutics (MRTX) United States $7.175B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.689B 0.00
Novavax (NVAX) United States $6.640B 0.00
Acceleron Pharma (XLRN) United States $6.383B 0.00
Adaptive Biotechnologies (ADPT) United States $6.294B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.220B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.028B 186.74
Emergent Biosolutions (EBS) United States $5.324B 21.09
Ultragenyx Pharmaceutical (RARE) United States $5.021B 0.00
Zai Lab (ZLAB) China $4.606B 0.00
MorphoSys AG (MOR) Germany $4.503B 59.02
China Biologic Products (CBPO) China $4.408B 26.16
Blueprint Medicines (BPMC) United States $4.391B 0.00
Vir Biotechnology (VIR) United States $4.157B 0.00
Legend Biotech (LEGN) United States $4.136B 0.00
Arena Pharmaceuticals (ARNA) United States $4.107B 0.00
Denali Therapeutics (DNLI) United States $4.092B 0.00
NeoGenomics (NEO) United States $3.957B 1194.33
Halozyme Therapeutics (HALO) United States $3.801B 0.00
Amicus Therapeutics (FOLD) United States $3.778B 0.00
Bluebird Bio (BLUE) United States $3.752B 0.00
Reata Pharmaceuticals (RETA) United States $3.545B 0.00
Fate Therapeutics (FATE) United States $3.409B 0.00
Global Blood Therapeutics (GBT) United States $3.395B 0.00
Insmed (INSM) United States $3.386B 0.00
Principia Biopharma (PRNB) United States $3.330B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.161B 0.00
Twist Bioscience (TWST) United States $3.029B 0.00
Alkermes (ALKS) Ireland $2.868B 60.10
Inovio Pharmaceuticals (INO) United States $2.848B 0.00
PHARMA MAR SA (PHMMF) Spain $2.290B 0.00
Sorrento Therapeutics (SRNE) United States $2.282B 0.00
Intra-Cellular Therapies (ITCI) United States $2.117B 0.00
Editas Medicine (EDIT) United States $2.111B 0.00
Revance Therapeutics (RVNC) United States $2.106B 0.00
Mesoblast (MESO) Australia $2.098B 0.00
I-Mab (IMAB) China $2.092B 0.00
Zymeworks (ZYME) Canada $2.069B 0.00
Eidos Therapeutics (EIDX) United States $2.034B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.006B 22.47
Seres Therapeutics (MCRB) United States $1.956B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.862B 0.00
UniQure (QURE) Netherlands $1.853B 0.00
Akcea Therapeutics (AKCA) United States $1.844B 0.00
Viela Bio (VIE) United States $1.628B 0.00
Amarin (AMRN) Ireland $1.607B 0.00
Cytokineticsorporated (CYTK) United States $1.537B 0.00
Sangamo Therapeutics (SGMO) United States $1.525B 0.00
Beam Therapeutics (BEAM) United States $1.524B 0.00
Mersana Therapeutics (MRSN) United States $1.509B 0.00
Ligand Pharmaceuticals (LGND) United States $1.480B 50.04
Dicerna Pharmaceuticals (DRNA) United States $1.478B 0.00
Zealand Pharma (ZEAL) Denmark $1.451B 0.00
Arcus Biosciences (RCUS) United States $1.424B 0.00
Coherus BioSciences (CHRS) United States $1.422B 8.29
Intercept Pharmaceuticals (ICPT) United States $1.382B 0.00
Intellia Therapeutics (NTLA) United States $1.381B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.357B 0.00
Epizyme (EPZM) United States $1.346B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
NGM Biopharmaceuticals (NGM) United States $1.317B 0.00
Compugen (CGEN) Israel $1.290B 0.00
Alcobra (ARCT) United States $1.144B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.137B 0.00
REGENXBIO (RGNX) United States $1.118B 0.00
Alector (ALEC) United States $1.115B 0.00
Arvinas (ARVN) United States $1.098B 0.00
Athenex (ATNX) United States $1.073B 0.00
Retrophin (RTRX) United States $1.031B 0.00
Castle Biosciences (CSTL) United States $1.005B 0.00
Pliant Therapeutics (PLRX) United States $1.000B 0.00
Adverum Biotechnologies (ADVM) United States $0.999B 0.00
Myriad Genetics (MYGN) United States $0.966B 0.00
Agenus (AGEN) United States $0.950B 0.00
Heska (HSKA) United States $0.933B 0.00
NantKwest (NK) United States $0.917B 0.00
Morphic Holding (MORF) United States $0.885B 0.00
Cellectis S.A (CLLS) France $0.885B 0.00
Vericel (VCEL) United States $0.865B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.842B 0.00
Frequency Therapeutics (FREQ) United States $0.840B 0.00
VBI Vaccines (VBIV) United States $0.828B 0.00
Intrexon (PGEN) United States $0.810B 0.00
Protagonist Therapeutics (PTGX) United States $0.810B 0.00
Kadmon Holdings (KDMN) United States $0.770B 0.00
Codexis (CDXS) United States $0.720B 0.00
MiMedx (MDXG) United States $0.715B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
WAVE Life Sciences (WVE) Singapore $0.712B 0.00
Cara Therapeutics (CARA) United States $0.681B 0.00
Northwest Biotherapeutics (NWBO) United States $0.670B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.656B 0.00
AC Immune SA (ACIU) Switzerland $0.644B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Clovis Oncology (CLVS) United States $0.614B 0.00
Geron (GERN) United States $0.609B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Dynavax Technologies (DVAX) United States $0.595B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.591B 0.00
Albireo Pharma (ALBO) United States $0.583B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.580B 0.00
IVERIC Bio (ISEE) United States $0.563B 0.00
Forte Biosciences (FBRX) United States $0.555B 0.00
Kala Pharmaceuticals (KALA) United States $0.551B 0.00
Scholar Rock Holding (SRRK) United States $0.543B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.538B 4.71
Anika Therapeutics (ANIK) United States $0.519B 22.70
Cue Biopharma (CUE) United States $0.510B 0.00
Celldex Therapeutics (CLDX) United States $0.506B 0.00
MeiraGTx Holdings (MGTX) United States $0.506B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.503B 0.00
MannKind (MNKD) United States $0.477B 0.00
UROGEN PHARMA (URGN) United States $0.470B 0.00
Syros Pharmaceuticals (SYRS) United States $0.458B 0.00
Starpharma Holdings (SPHRY) Australia $0.457B 0.00
Avid Bioservices (CDMO) United States $0.449B 0.00
AnaptysBio (ANAB) United States $0.439B 0.00
Athersys (ATHX) United States $0.430B 0.00
Sutro Biopharma (STRO) United States $0.426B 0.00
Prothena (PRTA) Ireland $0.425B 0.00
Fortress Biotech (FBIO) United States $0.421B 0.00
Amryt Pharma (AMYT) United Kingdom $0.414B 0.00
Puma Biotechnology (PBYI) United States $0.411B 0.00
BioDelivery Sciences (BDSI) United States $0.411B 29.07
Xenon Pharmaceuticals (XENE) Canada $0.400B 0.00
Kamada (KMDA) Israel $0.390B 18.66
PDL BioPharma (PDLI) United States $0.380B 0.00
Merus (MRUS) Netherlands $0.376B 0.00
ANI Pharmaceuticals (ANIP) United States $0.374B 8.83
Cellular Biomedicine (CBMG) United States $0.363B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.351B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.351B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.349B 0.00
Trevena (TRVN) United States $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Precision BioSciences (DTIL) United States $0.311B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.304B 0.00
Innate Pharma S.A (IPHA) France $0.302B 0.00
Affimed (AFMD) Germany $0.290B 0.00
Cyclerion Therapeutics (CYCN) United States $0.285B 0.00
Prometic Life Sciences (LMNL) Canada $0.282B 0.00
OSMOTICA PHARM (OSMT) United States $0.281B 0.00
Selecta Biosciences (SELB) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
NextCure (NXTC) United States $0.263B 0.00
Arbutus Biopharma (ABUS) United States $0.260B 0.00
Pluristem Therapeutics (PSTI) Israel $0.258B 0.00
HOOKIPA Pharma (HOOK) United States $0.240B 0.00
Verastem (VSTM) United States $0.236B 0.00
Aduro Biotech (ADRO) United States $0.224B 0.00
TELA Bio (TELA) United States $0.222B 0.00
Dyadic (DYAI) United States $0.222B 0.00
Liquidia Technologies (LQDA) United States $0.219B 0.00
XOMA (XOMA) United States $0.218B 0.00
DBV Technologies S.A (DBVT) France $0.214B 0.00
Spero Therapeutics (SPRO) United States $0.214B 0.00
Kindred Biosciences (KIN) United States $0.208B 0.00
Cerecor (CERC) United States $0.208B 0.00
ADMA Biologics Inc (ADMA) United States $0.206B 0.00
Checkpoint Therapeutics (CKPT) United States $0.204B 0.00
Cardiff Oncology (CRDF) United States $0.202B 0.00
Theratechnologies (THTX) Canada $0.201B 0.00
Biofrontera AG (BFRA) Germany $0.200B 0.00
Eton Pharmaceuticals (ETON) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
GENFIT S.A (GNFT) France $0.179B 0.00
Exicure (XCUR) United States $0.179B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.177B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.174B 8.10
Aytu Bioscience (AYTU) United States $0.166B 0.00
AquaBounty Technologies (AQB) United States $0.166B 0.00
Aptinyx (APTX) United States $0.163B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.161B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.155B 0.00
Nicox SA (NICXF) France $0.149B 0.00
SESEN BIO, INC (SESN) United States $0.148B 0.00
Five Prime Therapeutics (FPRX) United States $0.148B 0.00
VTv Therapeutics (VTVT) United States $0.147B 0.00
Bellus Health (BLU) Canada $0.147B 0.00
Applied Genetic Technologies (AGTC) United States $0.141B 0.00
Celyad SA (CYAD) Belgium $0.136B 0.00
Cidara Therapeutics (CDTX) United States $0.134B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.134B 0.00
Gritstone Oncology (GRTS) United States $0.125B 0.00
Lumos Pharma (LUMO) United States $0.121B 0.00
Strongbridge Biopharma (SBBP) United States $0.120B 0.00
Orgenesis (ORGS) United States $0.118B 6.02
Vaccinex (VCNX) United States $0.114B 0.00
Unum Therapeutics (UMRX) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.112B 0.00
Enzo Biochem (ENZ) United States $0.111B 0.00
PHASEBIO PHARMA (PHAS) United States $0.107B 0.00
Antibe Therapeutics (ATBPF) Canada $0.107B 0.00
Catalyst Biosciences (CBIO) United States $0.106B 0.00
ARAVIVE, INC (ARAV) United States $0.100B 0.00
AIT Therapeutics (XAIR) United States $0.098B 0.00
Idera Pharmaceuticals (IDRA) United States $0.094B 0.00
Oncobiologics (OTLK) United States $0.088B 0.00
Bionano Genomics (BNGO) United States $0.085B 0.00
DiaMedica Therapeutics (DMAC) United States $0.082B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Evogene (EVGN) Israel $0.080B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.074B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.073B 0.00
Proteostasis Therapeutics (PTI) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.063B 0.00
Emmaus Life Sciences (EMMA) United States $0.063B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.061B 0.00
Curis (CRIS) United States $0.060B 0.00
Soligenix (SNGX) United States $0.060B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.054B 0.00
Stealth BioTherapeutics (MITO) United States $0.053B 76.25
Appili Therapeutics (APLIF) Canada $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Genetic Technologies (GENE) Australia $0.051B 0.00
Novogen (KZIA) Australia $0.049B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.049B 0.00
Signal Genetics (MGEN) United States $0.048B 0.00
Organovo Holdings (ONVO) United States $0.047B 0.00
CollPlant Holdings (CLGN) Israel $0.047B 0.00
IMMURON (IMRN) Australia $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
ATyr Pharma (LIFE) United States $0.041B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.033B 0.00
OvaScience (MLND) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.030B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Celsion (CLSN) United States $0.026B 0.00
Acorda Therapeutics (ACOR) United States $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Cesca Therapeutics (THMO) United States $0.024B 0.00
Spherix (AIKI) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00